Onur Cil, MD, PhD (he/him/his)

Assistant Professor
UCSF

Poster(s):

• (216) Approved drug lubiprostone is not a selective Clc-2 activator and its prosecretory effect primarily depends on CFTR in human intestinal epithelial cells
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET